COMMUNIQUÉS West-GlobeNewswire

Vital Therapies to Host Analyst R&D Day on May 24, 2018

11/05/2018 - 14:01

SAN DIEGO, May 11, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will host a live [...]

Cellectar Reports Recent Corporate Highlights and 2018 First Quarter Financial Results

11/05/2018 - 14:00

MADISON, Wis., May 11, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]

Samumed Announces Presentation at the 2018 American Thoracic Society (ATS) International Conference

11/05/2018 - 14:00

SAN DIEGO, May 11, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, a leader in Wnt signaling pathway research and development, today announced it will present preclinical data on the company’s investigational Wnt pathway [...]

Denali Therapeutics Reports First Quarter 2018 Financial Results

11/05/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., May 11, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI ), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, [...]

Spectral Announces First Quarter Results

11/05/2018 - 14:00

TORONTO, May 11, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT ), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its [...]

Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 17th

11/05/2018 - 14:00

AUSTIN, Texas, May 11, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (NASDAQ: SVRA ), an orphan lung disease company, announced today that the Company's Chief Executive Officer, Rob Neville, will present at the Bank of America [...]

Theratechnologies Announces That National Institutes of Health Will Support Study on EGRIFTA® (Tesamorelin for Injection) in Non-HIV Patients With Non-Alcoholic Fatty Liver Disease

11/05/2018 - 14:00

MONTREAL, May 11, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) today announced that the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) in the [...]

Theratechnologies annonce que les National Institutes of Health appuieront une étude avec EGRIFTA(MD) (tésamoréline pour injection) chez des patients séro-négatifs atteints de stéatose hépatique non alcoolique

11/05/2018 - 14:00

MONTRÉAL, 11 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) a annoncé aujourd’hui today que le National Institute of Diabetes and Digestive and Kidney Diseases des National Institutes of Health (NIH) aux [...]

Melinta Therapeutics Launches New Antibiotic Stewardship Program to Combat Growing Threat of Antimicrobial Resistance

11/05/2018 - 14:00

Part of Strong Company Presence at 2018 MAD-ID Annual Meeting NEW HAVEN, Conn., May 11, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and [...]

Celsion Corporation Reports First Quarter 2018 Financial Results and Provides Business Update

11/05/2018 - 14:00

Significant Progress in Phase III Liver Cancer and Phase I/II Ovarian Cancer Studies Supported with Solid Fundamentals and a Strong Balance Sheet Company to Hold Conference Call on Friday, May 11, 2018 at 11:00 a.m. EDT [...]

Cocrystal Pharma Reports 2018 First Quarter Financial Results and Provides Corporate Update

11/05/2018 - 14:00

ATLANTA, GA and BOTHELL, WA, May 11, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral [...]

Chi-Med to Present at Bank of America Merrill Lynch Annual Health Care Conference

11/05/2018 - 13:34

LONDON, May 11, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM:HCM) (Nasdaq: HCM ) announced today that Christian Hogg, Chief Executive Officer, will present at the Bank of America Merrill [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

11/05/2018 - 13:31

FIT Biotech Oy Company release May 11, 2018 at 2.30 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]

Cannabis Wheaton Announces Closing of Robinson's Cannabis Acquisition

11/05/2018 - 13:30

VANCOUVER, British Columbia, May 11, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (the " Company ") is pleased to announce that it has closed its previously announced acquisition (the " Transaction [...]

eFFECTOR Initiates Randomized Dosing in Phase 2 Checkpoint Combination Trial of eFT508 and Avelumab in Colorectal Cancer

11/05/2018 - 13:30

Dose escalation completed with 200 mg twice daily selected as Phase 2 dose for monotherapy and checkpoint combination trials SAN DIEGO, May 11, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the [...]

Aclaris Therapeutics to Present at the 2018 American Hair Research Summit

11/05/2018 - 13:00

WAYNE, Pa., May 11, 2018 (GLOBE NEWSWIRE) -- Paul Changelian, Ph.D., Vice President, Biology, Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), will speak at the 2018 American Hair Research Summit on “Preclinical to Clinical [...]

Trillium Therapeutics Reports First Quarter 2018 Financial and Operating Results

11/05/2018 - 13:00

Focusing TTI-621 clinical development on T-cell lymphoma TTI-621 received Orphan Drug Designation for the treatment of cutaneous T-cell lymphoma Preclinical data with TTI-622 (SIRPaFc IgG4) presented at AACR; cleared to [...]

Surgery Partners, Inc. to Present at Upcoming Investor Conferences

11/05/2018 - 13:00

NASHVILLE, Tenn., May 11, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) (“Surgery Partners”), a leading healthcare services company, today announced that management will present at the following [...]

Leap Therapeutics Reports First Quarter 2018 Financial Results

11/05/2018 - 13:00

Conference Call with DKN-01 Clinical Investigators Planned for May 18, 2018 CAMBRIDGE, Mass., May 11, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and [...]